88760517
Jan 15, 2020
pharmaceutical preparations and therapeutics for the treatment of neurodegenerative diseases and disorders, neurological diseases and disorders, microbiome-related conditions, diseases and disorders related to the gut-brain axis, Alzheimer's disease, Parkinson's disease, Ataxia, Huntington's disease, and amyotrophic lateral sclerosis (ALS)
Pharmaceuticals